AU2005285035B2 - Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS) - Google Patents
Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS) Download PDFInfo
- Publication number
- AU2005285035B2 AU2005285035B2 AU2005285035A AU2005285035A AU2005285035B2 AU 2005285035 B2 AU2005285035 B2 AU 2005285035B2 AU 2005285035 A AU2005285035 A AU 2005285035A AU 2005285035 A AU2005285035 A AU 2005285035A AU 2005285035 B2 AU2005285035 B2 AU 2005285035B2
- Authority
- AU
- Australia
- Prior art keywords
- lower alkyl
- phenyl
- compound
- methyl
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/34—Ethylene-urea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60915704P | 2004-09-10 | 2004-09-10 | |
| US60/609,157 | 2004-09-10 | ||
| PCT/US2005/032381 WO2006031715A2 (en) | 2004-09-10 | 2005-09-09 | Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2005285035A1 AU2005285035A1 (en) | 2006-03-23 |
| AU2005285035B2 true AU2005285035B2 (en) | 2012-03-22 |
Family
ID=36060597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005285035A Ceased AU2005285035B2 (en) | 2004-09-10 | 2005-09-09 | Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS) |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7531565B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1791821B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5031568B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101056862B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005285035B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2579514A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2422204T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006031715A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101103003A (zh) * | 2004-11-16 | 2008-01-09 | 詹森药业有限公司 | 用作选择性雄激素受体调节剂(sarms)的新的杂环衍生物 |
| US7709516B2 (en) * | 2005-06-17 | 2010-05-04 | Endorecherche, Inc. | Helix 12 directed non-steroidal antiandrogens |
| US8835426B2 (en) * | 2007-02-26 | 2014-09-16 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| JP5451611B2 (ja) * | 2007-07-26 | 2014-03-26 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックインヒビター |
| AR069207A1 (es) * | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
| CA2708303A1 (en) | 2007-12-11 | 2009-06-18 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| TW200934490A (en) * | 2008-01-07 | 2009-08-16 | Vitae Pharmaceuticals Inc | Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1 |
| WO2009094169A1 (en) * | 2008-01-24 | 2009-07-30 | Vitae Pharmaceuticals, Inc. | Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| CA2714532A1 (en) * | 2008-02-11 | 2009-08-20 | Vitae Pharmaceuticals, Inc. | 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| US8598160B2 (en) * | 2008-02-15 | 2013-12-03 | Vitae Pharmaceuticals, Inc. | Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| CA2718264A1 (en) * | 2008-03-18 | 2009-09-24 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| EP2291370B1 (en) | 2008-05-01 | 2013-11-27 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| TW201004945A (en) | 2008-05-01 | 2010-02-01 | Vitae Pharmaceuticals Inc | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| CA2723032A1 (en) * | 2008-05-01 | 2009-11-05 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| KR20110002492A (ko) | 2008-05-01 | 2011-01-07 | 비타이 파마슈티컬즈, 인코포레이티드 | 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제 |
| US8846668B2 (en) | 2008-07-25 | 2014-09-30 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| CA2729993A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| WO2010011314A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
| GB2463514C (en) * | 2008-09-11 | 2018-09-26 | Galapagos Nv | Imidazolidine compounds and uses therefor |
| JP5679997B2 (ja) | 2009-02-04 | 2015-03-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤 |
| TW201039034A (en) * | 2009-04-27 | 2010-11-01 | Chunghwa Picture Tubes Ltd | Pixel structure and the method of forming the same |
| UA109255C2 (ru) | 2009-04-30 | 2015-08-10 | Берінгер Інгельхайм Інтернешнл Гмбх | Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1 |
| KR20120061771A (ko) * | 2009-04-30 | 2012-06-13 | 비타이 파마슈티컬즈, 인코포레이티드 | 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제 |
| WO2011011123A1 (en) | 2009-06-11 | 2011-01-27 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| WO2011002910A1 (en) | 2009-07-01 | 2011-01-06 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| TW201124138A (en) * | 2009-09-02 | 2011-07-16 | Valletta Health B V | Imidazole-4-carboxylic acid for use in treating a disease related to extracellular reactive oxygen species |
| EP2496589B1 (en) | 2009-11-05 | 2014-03-05 | Boehringer Ingelheim International GmbH | Novel chiral phosphorus ligands |
| JP5964756B2 (ja) | 2010-02-04 | 2016-08-03 | ラジウス ヘルス,インコーポレイテッド | 選択的アンドロゲン受容体モジュレーター |
| PL2568806T3 (pl) | 2010-05-12 | 2017-03-31 | Radius Health, Inc. | Schematy lecznicze |
| EP2576570A1 (en) | 2010-05-26 | 2013-04-10 | Boehringer Ingelheim International GmbH | 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives |
| EP2582698B1 (en) | 2010-06-16 | 2016-09-14 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
| WO2011161128A1 (en) | 2010-06-25 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders |
| RU2434851C1 (ru) * | 2010-07-22 | 2011-11-27 | Александр Васильевич Иващенко | Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения |
| AU2011312490B2 (en) * | 2010-09-28 | 2015-06-25 | Radius Pharmaceuticals, Inc. | Selective androgen receptor modulators |
| CA2813671A1 (en) | 2010-11-02 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
| US20140329858A1 (en) * | 2011-12-05 | 2014-11-06 | Novartis Ag | Cyclic Urea Derivatives As Androgen Receptor Antagonists |
| WO2017223115A1 (en) | 2016-06-22 | 2017-12-28 | Radius Health, Inc. | Ar+ breast cancer treatment methods |
| BR112020023136A2 (pt) | 2018-05-14 | 2021-02-09 | Nuvation Bio Inc. | compostos de alvo de receptor de hormônio nuclear anticâncer |
| CN113811333B (zh) | 2019-05-14 | 2024-03-12 | 诺维逊生物股份有限公司 | 靶向抗癌核激素受体的化合物 |
| EP4058464A1 (en) | 2019-11-13 | 2022-09-21 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
| EP4313991A1 (en) | 2021-03-23 | 2024-02-07 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
| WO2022235585A1 (en) | 2021-05-03 | 2022-11-10 | Nuvation Bio Inc. | Anti-cancer nuclear hormone receptor-targeting compounds |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005217074A1 (en) * | 2004-02-28 | 2005-09-09 | Boehringer Ingelheim International Gmbh | Novel carboxamides for use as Xa inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2329276A1 (fr) * | 1975-10-29 | 1977-05-27 | Roussel Uclaf | Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant |
| TW521073B (en) * | 1994-01-05 | 2003-02-21 | Hoechst Marion Roussel Inc | New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them |
| FR2715402B1 (fr) | 1994-01-05 | 1996-10-04 | Roussel Uclaf | Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
| FR2724169B1 (fr) | 1994-09-06 | 1997-01-03 | Roussel Uclaf | Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
| DE102004009835A1 (de) * | 2004-02-28 | 2005-09-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel |
-
2005
- 2005-09-09 CA CA002579514A patent/CA2579514A1/en not_active Abandoned
- 2005-09-09 CN CN2005800381110A patent/CN101056862B/zh not_active Expired - Fee Related
- 2005-09-09 AU AU2005285035A patent/AU2005285035B2/en not_active Ceased
- 2005-09-09 ES ES05800947T patent/ES2422204T3/es not_active Expired - Lifetime
- 2005-09-09 WO PCT/US2005/032381 patent/WO2006031715A2/en not_active Ceased
- 2005-09-09 US US11/223,187 patent/US7531565B2/en active Active
- 2005-09-09 JP JP2007531421A patent/JP5031568B2/ja not_active Expired - Fee Related
- 2005-09-09 EP EP05800947.3A patent/EP1791821B1/en not_active Expired - Lifetime
-
2009
- 2009-03-30 US US12/413,873 patent/US7968580B2/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005217074A1 (en) * | 2004-02-28 | 2005-09-09 | Boehringer Ingelheim International Gmbh | Novel carboxamides for use as Xa inhibitors |
Non-Patent Citations (4)
| Title |
|---|
| FERM R. J. et al, J. Organic Chem., 1952, 17(2), 181-184 * |
| GOUBET F. et al, Tetrahedron Letters, 1996, 37(43), 7727-7730 * |
| KIM T. H. et al, J. Organic Chem., 1999, 64(8), 2941-2943 * |
| SCHOLLKOPF U. et al, Liebigs Ann. Chem., 1980, 4, 600-610 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US7968580B2 (en) | 2011-06-28 |
| CN101056862A (zh) | 2007-10-17 |
| US20060063819A1 (en) | 2006-03-23 |
| EP1791821A2 (en) | 2007-06-06 |
| JP5031568B2 (ja) | 2012-09-19 |
| CN101056862B (zh) | 2013-03-13 |
| JP2008512492A (ja) | 2008-04-24 |
| WO2006031715A2 (en) | 2006-03-23 |
| EP1791821B1 (en) | 2013-06-05 |
| US7531565B2 (en) | 2009-05-12 |
| AU2005285035A1 (en) | 2006-03-23 |
| US20090215848A1 (en) | 2009-08-27 |
| ES2422204T3 (es) | 2013-09-09 |
| WO2006031715A3 (en) | 2006-07-20 |
| CA2579514A1 (en) | 2006-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1791821B1 (en) | Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms) | |
| RU2135469C1 (ru) | Производные n-сульфонил-2-оксо-индола, способ их получения, промежуточные продукты и фармацевтическая композиция, имеющая агент, активный в отношении рецепторов вазопрессина и/или оцитоцина | |
| JP5070042B2 (ja) | 選択的アンドローゲン受容体モジュレーター(sarms)としての新規インドール化合物 | |
| TWI483725B (zh) | 作為選擇性雄激素受體調節劑之新穎雜環衍生物 | |
| BRPI0620081A2 (pt) | composto derivado de benzimidazol e composição farmacêutica | |
| BRPI0610150A2 (pt) | composto, pró-droga, processo para produzir o composto, composição farmacêutica, antagonista do receptor de crf, e, uso do antagonista do receptor de crf | |
| JPH08109169A (ja) | 非ペプチドタキキニン受容体拮抗物質 | |
| JP2005501019A (ja) | 5−ht6レセプター親和性を有する4−ピペラジニルインドール誘導体 | |
| CZ20032696A3 (cs) | Thiohydantoiny a jejich použití při léčení cukrovky | |
| JP4917018B2 (ja) | 選択的アンドローゲン受容体モジュレーター(sarms)としての新規インドール化合物 | |
| CZ20023967A3 (cs) | Deriváty 3-azabicyklo[3,1,0]hexanu vykazující afinitu k opiátovým receptorům | |
| JP5070041B2 (ja) | 選択的アンドローゲン受容体モジュレーター(sarms)としての新規インドール化合物 | |
| CA2427394A1 (en) | 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives | |
| KR20100135248A (ko) | 인돌리논 화합물 | |
| JP5230448B2 (ja) | 選択的アンドローゲン受容体モジュレーターとして有用な新イミダゾロピラゾール誘導体 | |
| TWI737696B (zh) | 苯磺醯基不對稱尿素及其醫學用途 | |
| Tatsuta et al. | Benzimidazoles as non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 3: Discovery of 1-(1H-benzimidazol-5-yl)-3-tert-butylurea derivatives | |
| RU2685501C1 (ru) | Амидсодержащие производные 2-оксиндола, способ их получения и применения | |
| JP2001525398A (ja) | 選択的β3アドレナリン作動性アゴニスト | |
| KR20080080593A (ko) | 3-아미노-1-아릴프로필 인돌의 합성 방법 | |
| JP2001506605A (ja) | 2―アミノ―2―イミダゾリン、グアニジン、および2―アミノ―3,4,5,6―テトラヒドロピリミジン誘導体の製造法 | |
| WO2022022388A1 (zh) | 一种地佐辛衍生物晶型a及其制备方法和应用 | |
| Kiyoi et al. | Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists | |
| US6133453A (en) | Method for making substituted indoles | |
| CA2587936A1 (en) | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |